A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy Subjects
Clinical trial NCT06350279 · COMPLETED
Trial details
- NCT number
- NCT06350279
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-25
- Primary completion
- 2024-08-02
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.